- Home
- CDNA vs HUYA Comparison
CDNA vs HUYA Comparison
Compare CDNA & HUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- HUYA
- Stock Information
- Founded
- CDNA 1998
- HUYA 2014
- Country
- CDNA United States
- HUYA China
- Employees
- CDNA N/A
- HUYA N/A
- Industry
- CDNA Medical Specialities
- HUYA Computer Software: Programming Data Processing
- Sector
- CDNA Health Care
- HUYA Technology
- Exchange
- CDNA Nasdaq
- HUYA Nasdaq
- Market Cap
- CDNA 712.2M
- HUYA 827.0M
- IPO Year
- CDNA 2014
- HUYA 2018
- Fundamental
- Price
- CDNA $15.19
- HUYA $3.29
- Analyst Decision
- CDNA Buy
- HUYA Buy
- Analyst Count
- CDNA 8
- HUYA 3
- Target Price
- CDNA $26.86
- HUYA $4.57
- AVG Volume (30 Days)
- CDNA 1.3M
- HUYA 1.3M
- Earning Date
- CDNA 11-03-2025
- HUYA 11-11-2025
- Dividend Yield
- CDNA N/A
- HUYA 75.92%
- EPS Growth
- CDNA N/A
- HUYA N/A
- EPS
- CDNA 1.00
- HUYA N/A
- Revenue
- CDNA $340,826,000.00
- HUYA $852,782,043.00
- Revenue This Year
- CDNA $12.73
- HUYA $8.21
- Revenue Next Year
- CDNA $11.90
- HUYA $5.23
- P/E Ratio
- CDNA $15.23
- HUYA N/A
- Revenue Growth
- CDNA 14.72
- HUYA N/A
- 52 Week Low
- CDNA $10.96
- HUYA $2.21
- 52 Week High
- CDNA $32.76
- HUYA $6.43
- Technical
- Relative Strength Index (RSI)
- CDNA 60.38
- HUYA 44.69
- Support Level
- CDNA $14.28
- HUYA $3.21
- Resistance Level
- CDNA $15.21
- HUYA $3.41
- Average True Range (ATR)
- CDNA 0.60
- HUYA 0.11
- MACD
- CDNA 0.02
- HUYA -0.02
- Stochastic Oscillator
- CDNA 72.48
- HUYA 22.54
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About HUYA HUYA Inc. American depositary shares each representing one ordinary share
Established in 2011, Huya is the largest online game livestreaming company in China. Headquartered in Guangzhou, Huya mainly provides livestreamed videos on esports games such as League of Legends and Honor of Kings and collects virtual tips from viewers. Its products include the Huya Live platform in China and Nimo TV in Southeast Asia and South America. As of 2024, Huya was a subsidiary of Tencent, which owned 63% of its equity stake and held 94% of the voting power.